Imagine Pharma is focused on commercializing programs built around its novel IMG-1 polypeptide, with three distinct platforms targeting oral delivery, therapeutics, and regenerative medicine. The company is led by co-CEOs Dr. Ngoc Thai (Founder) and Santiago Pujadas and is based in Pittsburgh, PA. Its pipeline includes a nutritional supplement for commercialization and therapeutic programs such as oral erythropoietin and GLP-1 receptor agonists that are advancing toward completion of preclinical studies and IND submissions. Imagine Pharma also supports an AIPC research collaboration with LyGenesis and operates an islet isolation services business; it is an approved Islet Isolation Center for the NIDDK Integrated Islet Distribution Program. The company intends to use new funds to advance priority programs, expand islet services, and develop strategic partnerships across its platforms. Founded in 2016, the company has built programs addressing multiple disease states in large, underserved markets.

Total raised

$33M

Funding rounds

1

Latest round

Series A

Latest activity

Oct 2023